Quick response15 Jul 2024 14:30
To those now attempting to scare people off by suggesting they've done some research in the last half an hour and have a more accurate picture of where GDR stands as of today than anyone else.....and I've been invested for nearly 5 yrs now btw with one very brief opt out when the sp reached 3.5p shortly before the recent huge dilution.
When GDR was approaching the NICE news for AIHL last year (Jan to March) there were I think about 100m shares in issue and the share price reached 30p giving a mcap of something in the region of £30m. At this point in time GDR had little or no cash left in the bank - the ill fated River Fort deal was about to be announced just a day after the NICE announcement - and CYP2C19 was still a long way from receiving its own validation process by NICE.
Some 16 months on AIHL is due to be upgraded by NICE to Full recommendation before the end of 2024, CYP2C19 is about to receive Full recommendation from NICE and....GDR has about £5m left in the bank. It will also receive the usual R&D tax rebate, more money from Devote Grant and it's now generating a modest income from AIHL. I will be very surprised, and not a little disappointed, if the mcap isn't at about £30m mark again or even a bit higher as we approach the days before end of this month. That would give us a share price of about nearly 6p. I think this is absolutely doable even after all the huge recent dilution. With some extra tail winds I hope the sp might even hit 7 or 8p.